CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group

Authors: Michael Pfreundschuh, Evelyn Kuhnt, Lorenz Trümper, Anders Österborg, Marek Trněný, Lois E. Shepherd, Devinder Gill, Jan Walewski, Ruth Pettengell, Ulrich Jaeger, Pier Luigi Zinzani, Ofer Shpilberg, Stein Kvaløy, Peter de Nully Brown, Rolf A. Stahel, Nöel Milpied, Armando López‐Guillermo, Viola Poeschel, Sandra Graß, Markus Loeffler, Niels Murawski - The Lancet 2011 cited by 811